New nference Study Identifies Distinctive Characteristics of SARS-CoV-2 Variants Using Genomic Diversification
Results validate company’s methodology and provide insight about the rapid evolution of future variants of concern CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, an AI-driven health technology company, today announced the publication of a preprint study in medRxiv, validating the company’s methodology for characterizing SARS-CoV-2 evolution. The study provides the first compelling genomic signal…